American Portfolios Advisors - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 151 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2022$311,483
+14.0%
46,490
+8.2%
0.01%
+18.2%
Q2 2022$273,162
+37.1%
42,9500.0%0.01%
+57.1%
Q1 2022$199,288
-6.7%
42,950
+0.6%
0.01%0.0%
Q4 2021$213,575
-40.0%
42,715
+44.5%
0.01%
-46.2%
Q3 2021$356,198
-40.8%
29,560
+4.0%
0.01%
-43.5%
Q2 2021$601,400
-14.4%
28,435
+13.5%
0.02%
-25.8%
Q1 2021$702,933
+21.9%
25,060
+13.0%
0.03%
+3.3%
Q4 2020$576,810
-25.7%
22,185
+6.2%
0.03%
-33.3%
Q3 2020$776,667
+2.6%
20,895
+41.6%
0.04%
-8.2%
Q2 2020$757,079
+102.7%
14,755
+24.6%
0.05%
+58.1%
Q1 2020$373,473
+41.7%
11,845
+168.0%
0.03%
+63.2%
Q4 2019$263,565
+70.4%
4,420
+4.7%
0.02%
+46.2%
Q3 2019$154,705
-17.3%
4,220
+5.0%
0.01%
-18.8%
Q2 2019$187,010
+7.8%
4,020
-6.9%
0.02%0.0%
Q1 2019$173,448
-1.9%
4,320
+12.4%
0.02%
-27.3%
Q4 2018$176,870
+3.7%
3,8450.0%0.02%
+10.0%
Q3 2018$170,603
+38.4%
3,845
+22.3%
0.02%
+17.6%
Q2 2018$123,253
-68.9%
3,145
-42.6%
0.02%
-71.2%
Q1 2018$396,007
+9.9%
5,4750.0%0.06%
+3.5%
Q4 2017$360,4745,4750.06%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders